Encephalopathy in children: an approach to assessment and management

Emily Davies1, Daniel J Connolly, Santosh R Mordekar

  • 1Department of Paediatric Neurology, Sheffield Children’s Hospital, NHS Foundation Trust, Sheffield, UK.

Insights

Childhood encephalopathy requires prompt emergency care and appropriate investigations to determine the cause. This review guides clinicians in selecting tests and outlines treatments for common encephalopathy causes to improve patient outcomes.

Area of Science:

  • Pediatrics
  • Neurology
  • Clinical Medicine

Background:

  • Childhood encephalopathy is a serious condition with high mortality and morbidity.
  • It presents non-specifically, posing diagnostic challenges for clinicians.
  • Selecting appropriate investigations is crucial for timely diagnosis and management.

Purpose of the Study:

  • To provide a clinical approach for selecting investigations in childhood encephalopathy.
  • To outline management strategies for common causes of encephalopathy.
  • To aid general pediatricians in diagnosing and treating encephalopathic children.

Main Methods:

  • Review of clinical approaches to childhood encephalopathy.
  • Overview of diagnostic investigations, including neuroimaging.
  • Summary of evidence-based treatments for common encephalopathy etiologies.

Main Results:

  • Encephalopathy management requires initial emergency care followed by cause-specific therapies.
  • Diagnostic yield is maximized by appropriate selection of investigations.
  • Effective treatment significantly influences patient outcomes.

Conclusions:

  • A structured clinical approach aids in identifying the cause of childhood encephalopathy.
  • Timely and appropriate treatment is essential for improving outcomes.
  • This review offers practical guidance for pediatricians managing encephalopathy.

Related Concept Videos

Hepatic Encephalopathy01:29

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
Encephalitis l: Introduction01:19

Encephalitis l: Introduction

Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...